ClinicalTrials.gov
public full text
Public Domain
Observational Study of Patients With Moderate to Severe Chronic Plaque Psoriasis
This study will assess the use of risankizumab in adult patients with moderate to severe chronic plaque psoriasis and compare risankizumab to other commonly used biologics.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Risankizumab Versus Secukinumab for Participants With Moderate to Severe Plaque Psoriasis#828739
- A Multicenter Study of 074-6751 Lotion in Subjects With Moderate Plaque Psoriasis#1031558
- Study to Assess the Change in Disease State When Subcutaneous Risankizumab Injection is Given to Adult Participants With Psoriasis in Taiwan#847549
- Risankizumab Therapy Versus Placebo for Subjects With Psoriasis in the Russian Federation#1047507
- A Study of Tildrakizumab in Pediatric Subjects With Chronic Plaque Psoriasis#1161710
Record · ID 1372642
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive